First drug approved to treat MS in patients as young as 10 years old
Six states will also participate in the litigation
Drug used in combination with bortezomib, melphalan, and prednisone
Scientists find new molecular target for developing safer pain medications
Kymriah now indicated for relapsed or refractory diffuse large B cell lymphoma
This is the third indication granted for the co-administered drugs
Approval based on clinical studies and real-world evidence
Lowest, total-volume preparation bowel cleanser available in U.S.
Gemcitabine flush is cost-effective and potentially “practice-changing”


Perspectives on the Opioid Crisis With Dr. David B. Nash

Dr. David B. Nash, Dean of the Jefferson College of Population Health, talks about the national opioid emergency with Lyn Chesna, Managing Editor of P&T. Dr. Nash describes how population health professionals, big pharma, and nonprofit organizations, such as the 1889 Foundation and the Pharmacy Quality Alliance, are addressing the issue. 

April 2018 interview

P&T May 2018
Table of Contents


FDA Implementation Slow, Industry Criticism Significant
The FDA is making progress but is still laboring to address safety concerns about compounded drugs, an issue taken up by the Drug Quality and Security Act in 2013.
The clinical manifestations of Gaucher disease, a rare genetic lysosomal storage disorder, are debilitating, and the neuronopathic forms of the disease are fatal. The authors describe the current and investigational therapies for treatment.
Health Care & Law
Appropriate risk management strategies must be employed for compounding and administering sterile products. We review the new credentialing, regulatory, and related legal aspects of gaining and maintaining compliance for these processes.
Through a retrospective chart review, researchers found a substantial opportunity for clinical pharmacists to guide appropriate treatment of skin and soft tissue infections.
A Saudi group describes their universally applicable tool developed to prioritize and optimize formulary considerations at their large institution.
Meeting Highlights
Key sessions reported on findings in noncardiac surgery, pharmacological agents in the setting of acute coronary syndromes, and cardiotoxicity of cancer therapy.


Medication Errors
Errors with flecainide suspension in children
Prescription: Washington
White House report on drug prices is a detailed road map
Approvals, new indications, regulatory activities, and more
Vancomycin hydrochloride for oral solution (Firvanq) for C. difficile-associated diarrhea and enterocolitis caused by S. aureus; dexamethasone intraocular suspension 9% (Dexycu) for the treatment of inflammation after eye surgery; and apalutamide (Erleada) for prostate cancer
Drug Forecast
Olaratumab (Lartruvo): an innovative treatment for soft tissue sarcoma